MyFinsight
Home
Blog
About
Contact
pmcb: the balance sheet
Download
Download image
Other assets
$7,688
Warrant asset femasys
$1,120,000
Warrant asset qcls - non
current
$9,530,000
Investment in preferred
stock qcls
$20,747,000
Intangible asset
$1,549,427
Prepaid expenses and
other current assets
$503,147
Convertible note receivable
femasys - current
$5,000,000
Warrant asset qcls -
current
$1,912,000
Marketable equity
securities
$201,190
Cash and cash
equivalents
$15,406,017
Total other assets
$32,954,115
Total current assets
$23,022,354
Total assets
$55,976,469
Total liabilities,
temporary equity and...
$55,976,469
Total stockholders
equity
$35,235,089
Total temporary
equity
$1,318,996
Total liabilities
$19,422,384
Accumulated other
comprehensive loss
-$24,127
Treasury stock, at cost,
14,876,316 shares as of...
$44,607,916
Accumulated deficit
-$100,747,031
Additional paid-in capital
$180,611,996
Contingently redeemable
warrants
$417,000
Convertible preferred
stock-Series CPreferred...
$901,996
Total other
liabilities
$17,845,000
Total current
liabilities
$1,577,384
Common stock
authorized 200,000,000...
$2,167
Derivative liabilities
$1,693,000
Warrant liabilities
$16,152,000
Accrued series c
dividends
$35,389
Accrued expenses
$520,656
Accounts payable
$1,021,339
Back
Back
Balance Sheet
source: myfinsight.com
PharmaCyte Biotech, Inc. (PMCB)
PharmaCyte Biotech, Inc. (PMCB)